Article
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
29 Aug 2022
Abstract excerpt
NPM1 is the most frequently mutated gene in adults with acute myeloid leukemia (AML). The interaction between mutant NPM1 (NPM1c) and exportin-1 (XPO1) causes aberrant cytoplasmic dislocation of NPM1c and promotes the high expression of homeobox (HOX) genes, which is critical for maintaining the leukemic state of NPM1-mutated cells. Although there is a rationale for using XPO1 inhibitors in NPM1-mutated AML,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
